EFFECT OF LONG-TERM USE OF CPAP THERAPY ON WEIGHT DYNAMICS IN PATIENTS WITH SEVERE OSA

Abstract

At the clinic of propaedeutics of internal diseases, 33 patients were selected for whom a severe degree of OSA was diagnosed by cardiorespiratory monitoring (YAG ≥ 30 sob / h). All patients had a history of drowsiness (drowsiness school according to the Epworth questionnaire 12 ± 3), the presence of snoring during sleep, and short-term respiratory arrest. Two groups were formed using telephone monitoring: the first group was patients with severe OSAS who purchased a device for CPAP therapy (15 people, 13 of them were men and 2 women), the second group were patients with severe OSAS who did not buy or only are going to purchase a device for CPAP therapy (18 people, 17 of them are men and 1 woman). When analyzing the data, it was found that patients who purchased a device for CPAP therapy 85% have good compliance with the therapy, use the device> 4 hours per night 80% of the nights. With good compliance with therapy, the average weight of the patients of the first group before the start of therapy was 132 ± 8 kg, then at the time of the survey the average weight decreased to 118 ± 5 kg. In patients of the second group without CPAP therapy, the average weight was 111 ± 8 kg, after a trial course and recommendations from the attending physician for weight loss, at the time of the survey, the average weight of the group decreased to 105 ± 5 1 kg. Based on these data, it can be concluded that patients of the first group on CPAP therapy reduced their weight from the original by 1%, in contrast to the second group, where the weight decreased by 6%. According to the results of the study, patients with OSAS who have good compliance with therapy have a higher percentage in weight loss compared with patients without CPAP therapy.

Keywords

obstructive sleep apnea syndrome / breathing disorders during sleep / snoring / obesity / compliance / CPAP therapy

References

[1] 1. Горбунова, М.В. Динамика артериального давления и сосудистой жёсткости в зависимости от длительности ночных сеансов CPAP - терапии у пациентов с тяжёлым течение обструктивного апноэ сна / М.В. Горбунова, С.Л. Бабак, Т.В. Адашева, А.Г. Малявин // Ар-хивъ внутренней медицины. - 2019. - №4. - С.280-289.

[2] 2. Горбунова, М.В. Современные алгоритмы диагностики и лечения кардиоваскулярных и метаболических нарушений у пациентов с обструктивным апноэ сна / М.В. Горбунова, С.Л. Бабак, А.Г. Малявин // Лечебное дело. - 2019. - №1. - С.20-29.

[3] 3. Кучмин, А.Н. Динамика артериального давления у пациентов с синдромом обструктивного апноэ во сне / А.Н. Кучмин, А.Н. Куликов, [и др.] // Вестник Военно-медицинской академии. - 2016. - №56(4). - С.87-90.

[4] 4. Галактионов, Д.А. СРАР-терапия - фактор защиты сердечно-сосудистой системы у пациентов с тяжелой степенью синдрома об-структивного апноэ во сне / Д.А. Галактионов, А.А Казаченко [и др.] // Артериальная гипертензия. - 2017. - №4. - С.313-324.

[5] 5. Thunström, E. Blood pressure response to losartan and continuous positive airway pressure in hypertension and obstructive sleep apnea / E. Thunström, K. Manhem, A. Rosengren [et al.] // Am. J. Respir. Crit. Care Med. - 2016. - №193. - P.310-320.

[6] 6. Chirinos, J.A. CPAP, weight loss, or both for obstructive sleep apnea / J.A. Chirinos, I. Gurubhagavatula, K. Teff [et al.] // N. Engl. J. Med. - 2014. - Р.2265-2275.

RIGHTS & PERMISSIONS

Zhoglo A.O., Molchanov A.S., Cherniakhovska A.A.